RNU6-717P

Across TCGA pan-cancer cohorts, RNU6-717P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-717P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RNU6-717P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-717P expression acts as an unfavorable survival marker.

ESCA, CESC, and STAD are the cancer types where RNU6-717P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.198	0.872	.003	63	view →
CESC	OS	Tertile	All	0.013	0.875	<.001	36	view →
STAD	OS	Tertile	II,III,IV	0.160	0.571	.017	27	view →
OV	DFS	Tertile	IV	0.100	0.464	.044	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-717P–ESCA (OS)

Open the ESCA breakdown →